Harnessing Microbes to Produce Tirzepatide: A New Frontier in Diabetes Treatment
Tirzepatide, a revolutionary treatment for type 2 diabetes, has emerged as a significant advancement in the management of this chronic condition. Marketed by Eli …
India’s Visionary Leap: Redefining 2024 Global Biotech Landscape
In recent years, India has emerged as a formidable player in the global biotechnology arena. With an ecosystem rich in innovation, strategic government support, …
AI’s Top 15: Biotech’s Drug Discovery Leaders
In 2024, artificial intelligence (AI) is revolutionizing biotechnology, particularly in drug discovery. AI is reshaping the development of new therapies, making personalized medicine increasingly …
Sustainable Advances in Microbial Fermentation: Science Meets Ecology
Microbial fermentation, an age-old biotechnological process, is undergoing a remarkable transformation, catalyzed by advancements in science and an urgent need for sustainable solutions. This …
FDA Approves Earlier Use of Abecma CAR-T Therapy for Myeloma
CART Therapy Illustration The FDA has approved Bristol Myers Squibb and 2seventy Bio's CAR-T therapy, Abecma, for earlier use in treating multiple myeloma, a …
Onego Bio’s Leap in Animal-Free Egg Production
Onego Bio Secures $40M Funding: In a major advancement, Onego Bio has successfully concluded a $40 million Series A funding, aimed at scaling its …
AI’s Leap in Gene Therapy: Transforming Viral Vector Design
In the cutting-edge realm of biopharmaceuticals and biotechnology, the design of viral vectors emerges as a cornerstone of innovation, holding the key to groundbreaking …
ARCA and Oruka: New Era in Skin Care
In a strategic move aimed at transforming the treatment landscape for chronic skin diseases, ARCA biopharma, Inc. and Oruka Therapeutics have agreed to a …
“10x Genomics Launches Visium HD: A Leap in Spatial Biology
Yesterday, 10x Genomics, Inc., a pioneer in the realms of single-cell and spatial biology, proudly announced the release of its Visium HD Spatial Gene …
Crash Course on mRNA Therapeutics and the CDMO Space
Understanding mRNA Therapy: A Primer mRNA (messenger RNA) therapy is a revolutionary approach in biotechnology that utilizes synthetic mRNA to instruct cells to produce …
Epigenetic Revolution: Redefining Medicine’s Frontier
The global epigenetics market is set to soar, projected to reach $6.35 billion by 2032 from $2.14 billion in 2023, according to a recent …
AbbVie’s Landos Biopharma Acquisition Sparks Stock Surge
Yesterday, Landos Biopharma (LABP) experienced a significant surge in its stock price, rising by an impressive 168%. This surge was fueled by AbbVie's acquisition …
Top 5 Microbiome Mavericks in 2024
In the vast universe of biopharma, a new constellation of stars is rising, promising to redefine our approach to health and disease. These are …
2024 CDMO Sector Evolution: Key Trends
In 2024, the CDMO sector is navigating through transformative changes driven by customer needs, agility, digitalization, and environmental sustainability. These trends are shaping the …